High BMI Increases Complications for Chest Masculinization Surgery
By Lori Solomon HealthDay Reporter
FRIDAY, Nov. 17, 2023 -- Among transgender and nonbinary patients undergoing chest masculinization surgery (CMS), people with high body mass index (BMI) have a slightly increased risk for complications, although the risk for serious complications is very low, according to a study published online Nov. 1 in the Annals of Plastic Surgery.
Bashar Hassan, M.D., from Johns Hopkins University in Baltimore, and colleagues examined the association between BMI and postoperative complications among transgender and nonbinary patients undergoing CMS. The analysis included 2,317 patients (median BMI was 27.4 kg/m2; range, 15.6 to 64.9 kg/m2).
The researchers found that while increasing BMI was significantly associated with greater odds of at least one complication, no patients experienced severe morbidity, regardless of BMI. Compared with patients without obesity, those with BMI ≥50 kg/m2 had tripled odds of at least one complication (adjusted odds ratio, 3.63) and 36.62-fold greater odds of urinary tract infection. Similarly, patients with BMI ≥35 kg/m2 had fivefold greater odds of readmission and surgical site infection compared with patients without obesity.
"Given the low risk for severe complications in higher BMI individuals, we recommend re-evaluation of BMI cutoffs for CMS patients," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Lesbian, Bisexual Women Face Premature Death Versus Heterosexual Women
TUESDAY, May 7, 2024 -- Female nurses identifying as lesbian or bisexual have markedly earlier mortality than heterosexual nurses, according to a study published online April 25...
Evidence Lacking for Gender Dysphoria Treatments for Teens
FRIDAY, April 12, 2024 -- Evidence is lacking for use of puberty blockers and hormone treatment for gender dysphoria/incongruence, according to two systematic reviews published...
High Rate of PrEP Discontinuation Seen for Sexual Gender-Minority People
THURSDAY, March 14, 2024 -- Among sexual and gender-minority people who initiate preexposure prophylaxis (PrEP) for HIV, the annual rate of discontinuation is between 35 and 40...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.